Authors: Ray, MJ Hales, M Marsh, N

Citation: Mj. Ray et al., Epsilon-aminocaproic acid promotes the release of alpha(2)-antiplasmin during and after cardiopulmonary bypass, BL COAG FIB, 12(2), 2001, pp. 129-135

Authors: Degoute, CS Ray, MJ Manchon, M Dubreuil, C Banssillon, V

Citation: Cs. Degoute et al., Remifentanil and controlled hypotension; comparison with nitroprusside or esmolol during tympanoplasty, CAN J ANAES, 48(1), 2001, pp. 20-27

Authors: Ray, MJ Hales, MM Brown, L O'Brien, MF Stafford, EG

Citation: Mj. Ray et al., Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit, ANN THORAC, 72(2), 2001, pp. 521-526

Authors: Ray, MJ O'Brien, MF

Citation: Mj. Ray et Mf. O'Brien, Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: Efficiency, safety and cost, ANN THORAC, 71(3), 2001, pp. 838-843

Authors: Ray, MJ Brown, KF Burrows, CA O'Brien, MF

Citation: Mj. Ray et al., Economic evaluation of high-dose and low-dose aprotinin therapy during cardiopulmonary bypass, ANN THORAC, 68(3), 1999, pp. 940-945